EMV 3.27% $2.05 emvision medical devices ltd

Ann: Clinical Trial Stage 1 Enrolment Completed, page-16

  1. 2,109 Posts.
    lightbulb Created with Sketch. 346
    You need to take into account that this company is still somewhat of a startup. They're still trialling their products. There's not much liquidity in the market and stocks across the board are still down. I'm a fan. Just not holding yet. BOT's recent reversal is a good example of what EMV's SP will do at the right time.
    Last edited by 1lluminator: 21/02/23
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.